CORNING, N.Y., — Corning Life Sciences, a segment of Corning Incorporated (NYSE: GLW), will introduce the Corning® Synthemax® II-SC Substrate, a self-coating synthetic surface for stem cells, June 13-16 at the International Society for Stem Cell Research’s 10th annual meeting in Yokohama, Japan. The material creates a unique synthetic surface that mimics the natural cell […]
WALTHAM, Mass.– PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will establish a new Personalized Health Innovation Center of Excellence. The Center will focus on accelerating scientific innovation to help researchers who are working to eradicate disease and extend the quality and […]
The U.S. Department of Agriculture Food Safety and Inspection Service (FSIS) has issued a letter of no objection to DuPont’s claim that the BAX® System STEC suite is comparable to the FSIS reference method MLG 5B.01 for detecting top Shiga toxin-producing strains of E. coli (STEC). To determine the basis of the claim, the FSIS […]
A new culture medium for more physiologically relevant differentiation of human bronchial epithelial cells has been released by STEMCELL Technologies. Cells cultured with PneumaCult™-ALI at the air-liquid interface undergo extensive mucociliary differentiation to form a pseudostratified epithelium that closely resembles the human airway. “Culturing primary human bronchial epithelial cells at the air-liquid interface using current […]
MADISON, WIS., – Cellular Dynamics International, Inc. (CDI), the world’s largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, today announced the launch of its MyCell™ Services. These services include novel iPS cell line reprogramming, genetic engineering and differentiation of iPS cells into commercially available iCell® terminal tissue cells (for […]
SANTA CLARA, Calif — Affymetrix, Inc. (NASDAQ:AFFX) today announced a research collaboration and licensing agreement with Massachusetts General Hospital (MGH) to co-develop new cancer biomarker tests using the Affymetrix’ QuantiGene® ViewRNA Assay platform*, an in situ hybridization assay capable of single transcript in single-cell detection. As part of this agreement, Affymetrix has the rights to […]
CARLSBAD, Calif.,– MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of the PowerMag™ Soil and Microbial DNA Isolation Kits, for automated purification of DNA from soil, stool, microbial and food cultures using the epMotion® and KingFisher® automated processing systems. MO BIO’s novel MagnaClear™ technology, included in […]
Fluxion Biosciences, Inc. today announced an initial agreement to partner with Rubicon Genomics in a reagent supply and collaboration program. The collaboration will integrate enrichment methods for rare cells using Fluxion’s IsoFlux System with Rubicon’s technology for the preparation and amplification of rare cell DNA or RNA using the Rubicon NovaPLEX™ family of sample preparation […]
California, USA – DiscoveRx , a leader in innovative cell based assays for GPCRs, Kinases, NHRs and Proteases today unveiled a break-through technology called InCELL Hunter™. This platform marks a significant step forward as compared to other cell-based assay platforms currently available for Kinases, Epigenetics and other enzyme targets. This novel technology allows researchers to […]
TORONTO, – The Structural Genomics Consortium (SGC), a group of expert researchers in recombinant antibody technology from the Universities of Toronto and Chicago and an industry partner have entered into a pioneering public-private partnership to generate renewable recombinant antibodies for epigenetic targets. The first set of ten antibodies, released today, represent a major breakthrough in […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
